In a study of 1,027 ET patients, both type 1 and type 2 CALR mutations were associated with higher platelet counts, lower white blood cell counts, and lower hemoglobin levels than JAK2 mutations [37]. This evidence concerns the gene JAK2 and essential thrombocythemia.